COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1622: Articles 16211-16220  | Next

Contracting COVID-19: A Longitudinal Investigation of the Impact of Beliefs and Knowledge
Moore, C. A., Ruisch, B. C., Granados Samayoa, J. A., Boggs, S. T., Ladanyi, J. T., Fazio, R. H.
10.1101/2021.04.15.21255556 — Posted: 2021-04-20
Proteomic Profiling of MIS-C Patients Reveals Heterogeneity Relating to Interferon Gamma Dysregulation and Vascular Endothelial Dysfunction
Diorio, C., Shraim, R., Vella, L. A., Giles, J. R., Baxter, A. E., Oldridge, D. A., Canna, S. W., Henrickson, S. E., McNerney, K. O., Balamuth, F., Burudpakdee, C., Lee, J., Leng, T., Farrel, A., Lambert, M. P., Sullivan, K. E., Wherry, E. J., Teachey, D. T., Bassiri, H., Behrens, E. M.
10.1101/2021.04.13.21255439 — Posted: 2021-04-20
Forecast of the covid19 epidemic in France
Pottier, L.
10.1101/2021.04.13.21255418 — Posted: 2021-04-20
COVID-19 epidemic scenarios into 2021 based on observed key superdispersion events
Santana-Cibrian, M., Acuna-Zegarra, M. A., Rodriguez Hernandez-Vela, C. E., Velasco-Hernandez, J. X., Mena, R. H.
10.1101/2021.04.14.21255436 — Posted: 2021-04-20
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland
Shattock, A. J., Le Rutte, E. A., Duenner, R. P., Sen, S., Kelly, S. L., Chitnis, N., Penny, M. A.
10.1101/2021.04.14.21255503 — Posted: 2021-04-20
Cyclooxygenase inhibitor use is associated with increased COVID-19 severity
Reese, J., Coleman, B., Chan, L., Callahan, T. J., Cappelletti, L., Fontana, T., Bradwell, K. R., Harris, N. L., Casiraghi, E., Valentini, G., Karlebach, G., Deer, R., McMurry, J. A., Haendel, M. A., Chute, C. G., Pfaff, E., Moffitt, R., Spratt, H., Singh, J., Mungall, C. J., Williams, A. E., Robinson, P. N.
10.1101/2021.04.13.21255438 — Posted: 2021-04-20
Point-of-Care Ultrasound (POCUS) Predicts Clinical Outcomes in Patients with COVID-19.
Kumar, A., Weng, Y., Graglia, S., Lew, T., Gandhi, K., Lalani, F., Chia, D., Duanmu, Y., Jensen, T., Lobo, V., Nahn, J., Iverson, N., Rosenthal, M., Gordon, A., Kugler, J., Tran, M. C., Jia, X., Liao, C., Cha, A., Baum, E., Halket, D., Madhok, J., Fazal, M.
10.1101/2021.04.13.21255445 — Posted: 2021-04-20
A Real World Evaluation of the safety and immunogenicity of the Covishield vaccine, ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) in Health Care Workers (HCW) in National Capital Region (NCR) of India: A preliminary report
Kataria, S., Sharma, P., Deswal, V., Kumar, K., Singh, M. K., Alam, S., Gupta, V., Singh, P., Phogat, R., Sarma, S., Patil, N., Datt, R., Saxena, R., Trehan, N.
10.1101/2021.04.14.21255452 — Posted: 2021-04-20
Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan
Ishimaru, T., Okawara, M., Ando, H., Hino, A., Nagata, T., Tateishi, S., Tsuji, M., Matsuda, S., Fujino, Y.
10.1101/2021.04.13.21255442 — Posted: 2021-04-20
Choosing the right tool for the job: A comprehensive assessment of serological assays for SARS-CoV-2 as surrogates for authentic virus neutralization
Wohlgemuth, N., Whitt, K., Cherry, S., Kirkpatrick Roubidoux, E., Lin, C.-Y., Allison, K. J., Gowen, A., Freiden, P., Allen, E. K., St. Jude Investigative Team, , Gaur, A. H., Estepp, J. H., Tang, L., Mori, T., Hijano, D. R., McGargill, M. A., Krammer, F., Whitt, M. A., Wolf, J., Thomas, P. G., Schultz-Cherry, S.
10.1101/2021.04.14.21255399 — Posted: 2021-04-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).